206 related articles for article (PubMed ID: 6976792)
1. Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.
Vose BM; Gallagher P; Moore M; Schofield PF
Br J Cancer; 1981 Dec; 44(6):846-55. PubMed ID: 6976792
[TBL] [Abstract][Full Text] [Related]
2. Extravascular natural cytotoxicity in man: Anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes.
Moore M; Vose BM
Int J Cancer; 1981 Mar; 27(3):265-72. PubMed ID: 6169658
[TBL] [Abstract][Full Text] [Related]
3. Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.
Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
J Urol; 1988 Oct; 140(4):890-4. PubMed ID: 3262173
[TBL] [Abstract][Full Text] [Related]
4. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
5. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.
Mizutani Y; Okada Y; Yoshida O; Bonavida B
Cancer Biother Radiopharm; 1996 Dec; 11(6):385-91. PubMed ID: 10851499
[TBL] [Abstract][Full Text] [Related]
6. Lymph node anti-tumour effector cell mechanisms in colorectal carcinoma.
Werkmeister JA; Pihl E; Flannery GR
Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):115-24. PubMed ID: 7259635
[TBL] [Abstract][Full Text] [Related]
7. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
8. Cultured human T-cell lines kill autologous solid tumours.
Vose BM; Moore M
Immunol Lett; 1981 Oct; 3(4):237-41. PubMed ID: 6975752
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
Wilhelm SA; Mukherji B
J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
[TBL] [Abstract][Full Text] [Related]
10. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
[TBL] [Abstract][Full Text] [Related]
11. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
12. An analysis of autologous T-cell anti-tumour responses in colon-carcinoma patients following active specific immunization (ASI).
Patel BT; Lutz MB; Schlag P; Schirrmacher V
Int J Cancer; 1992 Jul; 51(6):878-85. PubMed ID: 1639535
[TBL] [Abstract][Full Text] [Related]
13. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
14. Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.
Radrizzani M; Gambacorti-Passerini C; Parmiani G; Fossati G
Cancer Immunol Immunother; 1989; 28(1):67-73. PubMed ID: 2462469
[TBL] [Abstract][Full Text] [Related]
15. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of regional lymph node lymphocytes in patients with lung cancer.
Yaita H; Yasumoto K; Nagashima A; Sugimachi K; Nomoto K
J Surg Oncol; 1988 Jul; 38(3):165-72. PubMed ID: 3260643
[TBL] [Abstract][Full Text] [Related]
17. Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF).
Kedar E; Ikejiri BL; Timonen T; Bonnard GD; Reid J; Navarro NJ; Sredni B; Herberman RB
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):757-73. PubMed ID: 6603361
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
19. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
Yanagawa E; Uchida A; Micksche M
Cancer Immunol Immunother; 1984; 17(1):1-6. PubMed ID: 6563940
[TBL] [Abstract][Full Text] [Related]
20. Role of autologous lymphocyte cytotoxicity in colonic neoplasia.
Gallagher P; Vose BM; Moore M; Schofield PF
Gut; 1982 Jan; 23(1):31-5. PubMed ID: 6976915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]